Detalhe da pesquisa
1.
Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells.
Nature
; 627(8004): 646-655, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38418879
2.
ctDNA guiding adjuvant immunotherapy in urothelial carcinoma.
Nature
; 595(7867): 432-437, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34135506
3.
Metabolic Diversity in Human Non-Small Cell Lung Cancer Cells.
Mol Cell
; 76(5): 838-851.e5, 2019 12 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31564558
4.
Publisher Correction: Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells.
Nature
; 627(8005): E11, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38480897
5.
Combined use of CYFRA 21-1 and CA 125 predicts survival of patients with metastatic NSCLC and stable disease in IMpower150.
Tumour Biol
; 46(s1): S177-S190, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-37545290
6.
First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer.
N Engl J Med
; 379(23): 2220-2229, 2018 12 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30280641
7.
Differential regulation of PD-L1 expression by immune and tumor cells in NSCLC and the response to treatment with atezolizumab (anti-PD-L1).
Proc Natl Acad Sci U S A
; 115(43): E10119-E10126, 2018 10 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-30297397
8.
A Phase II Randomized Trial (GO27827) of First-Line FOLFOX Plus Bevacizumab with or Without the MET Inhibitor Onartuzumab in Patients with Metastatic Colorectal Cancer.
Oncologist
; 22(3): 264-271, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28209746
9.
A Randomized Phase II Study of FOLFOX With or Without the MET Inhibitor Onartuzumab in Advanced Adenocarcinoma of the Stomach and Gastroesophageal Junction.
Oncologist
; 21(9): 1085-90, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27401892
10.
The mutation spectrum revealed by paired genome sequences from a lung cancer patient.
Nature
; 465(7297): 473-7, 2010 May 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-20505728
11.
NeuroD1 regulates survival and migration of neuroendocrine lung carcinomas via signaling molecules TrkB and NCAM.
Proc Natl Acad Sci U S A
; 110(16): 6524-9, 2013 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-23553831
12.
Genome and transcriptome sequencing of lung cancers reveal diverse mutational and splicing events.
Genome Res
; 22(12): 2315-27, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23033341
13.
The evolving genomic classification of lung cancer.
J Pathol
; 232(2): 121-33, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24114583
14.
Analytical evaluation of circulating tumor DNA sequencing assays.
Sci Rep
; 14(1): 4973, 2024 02 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38424110
15.
Immune heterogeneity in small-cell lung cancer and vulnerability to immune checkpoint blockade.
Cancer Cell
; 42(3): 429-443.e4, 2024 Mar 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38366589
16.
A longitudinal circulating tumor DNA-based model associated with survival in metastatic non-small-cell lung cancer.
Nat Med
; 29(4): 859-868, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36928816
17.
Circulating Tumor DNA Monitoring on Chemo-immunotherapy for Risk Stratification in Advanced Non-Small Cell Lung Cancer.
Clin Cancer Res
; 29(22): 4596-4605, 2023 11 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37702716
18.
Clinical and molecular characterization of long-term survivors with extensive-stage small cell lung cancer treated with first-line atezolizumab plus carboplatin and etoposide.
Lung Cancer
; 186: 107418, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37931445
19.
Oncogenic KRAS-induced interleukin-8 overexpression promotes cell growth and migration and contributes to aggressive phenotypes of non-small cell lung cancer.
Int J Cancer
; 130(8): 1733-44, 2012 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21544811
20.
The circadian clock gene BMAL1 is a novel therapeutic target for malignant pleural mesothelioma.
Int J Cancer
; 131(12): 2820-31, 2012 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22510946